Early Access — free while we kick the tires
EdgarHawk

ARQ Arq, Inc. Insider Trading

Latest: Director Bought $332K of Shares · Mar 2026
14 filings analyzed · Latest 2026-03-24
Insider buys
14
Insider sells
0
Unique insiders
7
Direction
Net buying
March 2026
2026-03-24
high
Campbell-Breeden Richard Buy
150,000 shares
$331,665
@ $2.21
Significance 7/10

Director Richard Campbell-Breeden buys 150.0K ARQ shares at $2.21; holds cluster buy pattern with 3 other insiders in 14 days

Director Richard Campbell-Breeden purchased 150,000 shares at $2.21 on 2026-03-23, increasing his holdings by 58.9% to 404.8K shares—a material increase. His prior two purchases at ARQ both delivered positive 90-day returns (6.1% and 73.7%), establishing a pattern of well-timed entry points at this ticker. This transaction occurs within a cluster of 3 other insider buys in the past 14 days, indicating coordinated buying despite the stock trading at -69.9% from its 52-week high and -32.7% over the past 30 days. The company is unprofitable (net income $-653.0K last quarter) with market cap $99.8M, creating a high-risk profile. The confluence of sustained insider accumulation, proven prior timing accuracy at this ticker, and steep recent price declines warrants attention to whether this represents informed conviction or opportunistic positioning into a distressed valuation.

2026-03-19
medium
Wong Joseph M Buy
Chief Technology Officer
10,000 shares
$18,900
@ $1.89
Significance 6/10

CTO buys 10,000 shares at $1.89; stock down 39.3% in 30 days, but insider's cross-ticker track record shows 100% 90-day win rate.

Joseph M Wong, Chief Technology Officer of Arq, Inc., purchased 10,000 shares at $1.89 on 2026-03-17, increasing his holdings to 400,686 shares. This purchase occurs against a backdrop of severe near-term price deterioration—the stock has fallen 39.3% over the past 30 days and 35.3% over 90 days, trading 73.2% below its 52-week high of $7.73. However, Wong's own cross-ticker open-market history demonstrates a 100% win rate on buys at the 90-day mark with an average 90-day return of 40.1%; his single prior purchase at ARQ in May 2025 also posted a 59.6% 90-day gain. The buy aligns with a cluster pattern: 2 other insiders bought within the past 14 days, suggesting shared conviction at current levels. The company generated $35.1M in quarterly revenue with annual growth of 10.4% but remains unprofitable ($-653.0K quarterly net income), narrowing the basis for timing confidence to either operational recovery expectations or valuation mechanics rather than current profitability. The coincidence of Wong's disciplined historical timing, his same-ticker prior success, and concurrent insider accumulation warrants investor attention to whether this signals management's view of a floor in the decline.

2026-03-17
high
EICHER CAROL S Buy
77,500 shares
$151,009
@ $1.95
Significance 7/10

Director EICHER CAROL S buys 77,500 shares at $1.95; coordinated cluster buy as stock down -75.6% from 52-week high.

Director Carol S Eicher purchased 77,500 shares at $1.95 on 2026-03-13, increasing her holdings by 80.3% to 174,010 shares total, while the stock trades at $1.89 after a -75.6% decline from its 52-week high of $7.73. This purchase occurs within a cluster pattern: 2 other insiders also bought within the past 14 days. The company faces recent headwinds—it reported a net loss of $653,000 in the latest quarter and was unprofitable over the most recent full fiscal year—yet maintains positive annual revenue growth of +10.4% and a market cap of $81.0M. The simultaneous buying activity by multiple directors at depressed price levels, combined with the stock's sharp 30-day decline of -47.4%, warrants investor attention to whether insiders view the recent weakness as an entry opportunity or whether underlying operational challenges remain unresolved.

2026-03-16
medium
Smith Claiborne Benson Buy
Gen Counsel, Corp Secretary
2,000 shares
$3,836
@ $1.92
Significance 5/10

Gen Counsel Smith Claiborne Benson buys 2,000 shares at $1.92 across 2 separate transactions; stock down 75.7% from 52-week high amid unprofitability.

Smith Claiborne Benson executed 2 separate purchases totaling 2,000 shares for $3,836.40 at a blended average price of $1.92 on March 12 and March 16, 2026. The timing is notable given that ARQ's stock trades at $1.88 (current price), down 75.7% from its 52-week high of $7.73 and down 47.6% over the past 30 days. However, the company reported a negative net income of $-653,000.00 for the latest quarter and was unprofitable over its most recent full fiscal year, even as annual revenue grew 10.4%. The purchases represent a 2.0% increase to Benson's holdings (from 100.5K to 102.5K shares), a modest incremental addition rather than a material concentration of new capital.

November 2025
2025-11-13
high
Campbell-Breeden Richard Buy
28,638 shares
$101,487
@ $3.54
Significance 6/10

Director Campbell-Breeden bought 28,638 shares of ARQ at $3.54 on 2025-11-11; stock down 54.9% from 52-week high, 2 other insiders also bought in 14-day cluster.

Director Richard Campbell-Breeden purchased 28,638 shares for $101,487.34 at $3.54, increasing his holdings by 12.7% to 254,786 shares. The transaction occurred as ARQ's stock trades 54.9% below its 52-week high of $7.92 and has declined 50.3% over the past 30 days. A cluster pattern is present: 2 other insiders also bought within the past 14 days. Campbell-Breeden's prior buy at this same ticker (2025-05-23) generated a 90-day return of +73.7%, demonstrating prior success with this stock's timing, though the company remains unprofitable with a net loss of $653.0K against revenue of $35.1M.

2025-11-13
high
Voncannon Jay Loring Buy
Chief Financial Officer
15,000 shares
$54,970
@ $3.66
Significance 7/10

ARQ CFO Jay Loring Voncannon buys 15,000 shares at $3.66–$3.74 blended average; 2 other insiders also bought within 14 days

Voncannon Jay Loring, CFO of Arq, Inc., executed 2 purchases totaling 15,000 shares for $54,970.20 on 2025-11-10 and 2025-11-11 at prices of $3.74 and $3.55, representing a 30.0% increase to his 65,000 share holdings. The timing follows a sharp 50.3% decline over the prior 30 days and a 54.9% drop from the 52-week high of $7.92. The company reported negative net income of $-653,000.00 in the latest quarter and was unprofitable over its most recent full fiscal year, though annual revenue growth was +9.9%. Most significantly, a cluster pattern is present: 2 other insiders also bought within the past 14 days, suggesting coordinated or reinforced conviction from multiple company leaders during a period of steep price depreciation. This multi-insider activity combined with heavy losses provides critical context: investors should monitor whether the accumulated insider purchases reflect confidence in a recovery or represent accumulation ahead of further deterioration.

2025-11-12
high
Rasmus Robert E. Buy
Chief Executive Officer
50,000 shares
$189,590
@ $3.79
Significance 7/10

CEO Rasmus Robert E. bought 50,000 shares of ARQ at $3.79; holdings jump 241.3% amid cluster buy and strong historical timing pattern at this ticker.

CEO Rasmus Robert E. purchased 50,000 shares at $3.79 on 2025-11-10, increasing his holdings from 20,718 to 70,718 shares (+241.3% change). This transaction occurs within a cluster of 2 other insider buys in the past 14 days, suggesting coordinated appetite at current levels. The CEO's own prior trading record at ARQ is notably strong: all 5 previous buys at this ticker were well-timed at the 90-day mark (with 90d returns ranging from +63.5% to +83.2%), and his cross-ticker track record shows a 100% 90d win rate across 6 prior buys with an average 90d return of +64.1%. However, context matters: the current stock price of $3.70 is -53.3% from the 52-week high and down -48.7% over the past 30 days, the company posted a net loss of $653,000 in the latest quarter, and annual profitability remains negative. The large position increase and cluster pattern suggest conviction at this valuation, but the deteriorating near-term price action and unprofitable fundamentals present material risk.

May 2025
2025-05-28
high
Blank Jeremy Buy
50,000 shares
$205,000
@ $4.10
Significance 7/10

Director Blank Jeremy bought 50,000 shares of ARQ at $4.10; director + 3 insiders bought within 14 days amid -38.3% decline from 52-week high.

Director Blank Jeremy purchased 50,000 shares at $4.10 on 2025-05-23, increasing his holdings to 374,955 shares, a +15.4% increase in his position. This transaction is part of a cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated insider accumulation. The purchase occurs while ARQ trades -38.3% from its 52-week high of $7.92, though the stock is up 32.9% over the past 30 days. The company reported Revenue $27,247,000.00 (latest quarter) and is unprofitable on a full-year basis (negative full-year net income), making this insider accumulation at depressed levels particularly noteworthy given the fundamental backdrop.

2025-05-28
medium
Rasmus Robert E. Buy
Chief Executive Officer
25,000 shares
$102,500
@ $4.10
Significance 6/10

CEO Rasmus Robert E. buys 25,000 shares of ARQ at $4.10 on 2025-05-23; 5 new buys in 14 days amid cluster activity.

Rasmus Robert E., as CEO of Arq, Inc., purchased 25,000 shares at $4.10 on 2025-05-23, bringing his holdings to 480.8K shares (+5.5% increase). This purchase is part of an accelerated buying pattern: 5 separate buys in 14 days at ARQ (May 9, 12, 13, 14, and 23), and 3 other insiders also bought within the past 14 days, forming a cluster buy pattern. Notably, the prior measurable ARQ purchase (2024-09-23) returned +27.0% at the 90-day mark, demonstrating a 100% win rate on that single historical trade. However, the company remains unprofitable on a full-year basis despite +9.9% annual revenue growth, and the stock trades 38.3% below its 52-week high of $7.92. The cluster activity and rapid cadence of CEO purchases in a short window merit tracking against near-term operational developments.

2025-05-27
high
Campbell-Breeden Richard Buy
75,000 shares
$307,500
@ $4.10
Significance 7/10

Director Campbell-Breeden bought 75.0K shares of ARQ at $4.10 on 2025-05-23 ($307.5K); cluster of 4 insiders buying within 14 days amid -9.7% 90-day decline.

Campbell-Breeden, a director, purchased 75,000 shares at $4.10 for $307,500.00, increasing his stake from 151,148 shares to 226,148 shares (+49.6% increase in holdings). This transaction is part of a cluster pattern in which 3 other insiders also bought within the past 14 days, suggesting coordinated or contemporaneous accumulation. The purchase occurred while the stock is -39.1% from its 52-week high of $7.92 and -9.7% over the past 90 days, despite a +32.0% rebound over the past 30 days. The company reported quarterly revenue of $27,247,000.00 and net income of $203,000.00, with +9.9% annual revenue growth, but was unprofitable over its most recent full fiscal year, creating a disconnect between revenue expansion and bottom-line results that warrants closer examination.

More Chemicals and Allied Products companies

Get alerts for ARQ

Add ARQ to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access